Using AI-derived CAC 0 on hybrid SPECT/CT in patients with normal perfusion can double the proportion of patients in whom stress-only procedures could be safely performed. @robertjhmiller @Piotr_JSlomka @SmidtHeart @CedarsSinai Read now👉 https://t.co/jPzR3jXMr9

Metabolic preparation strategies for FDG PET/CT myocardial viability imaging. @BrunoLimaMDPhD @PanithayaC @VUMChealth @MayoClinic Read now👉 https://t.co/S9gGAMP0A5 #cvnuc

Optimizing FDG PET/CT imaging in suspected prosthetic valve endocarditis. @erasmusuni Read now👉 https://t.co/A7dbmJy6vG #cvnuc

Thank you 🙏 Dr. Hendel & Dr. Stencel @TulaneCardio for your insightful editorial on our recent publication @JNCjournal @MyASNC ! Assessment of liver transplant candidates: ❓❓What tests De-liver❓❓ https://t.co/ELzOvBSpeB @attilafehermd @YaleCardiology #cvnuc

Use of Rb-82 PET MPI in risk assessment in challenging cases: Intrapericardial diaphragmatic hernia @BanuSathyamur14 @ParthibanArum18 @MFTNHS Read now👉 https://t.co/sEsyC2Opt7 #cvnuc

Consider imaging with HMDP prior to 3hrs as HMDP may wash out of the myocardium more quickly than PYP. @BrettSperryMD @ErikaHuttCe @MidAmericaHeart Read now👉 https://t.co/lKWVLrUlvJ #cvnuc

In a systematic review including 8 studies and 268 patients, the sensitivity and specificity of SPECT to detect significant reductions in MBF and MFR (using PET as the gold standard) were 80.8% and 87.0%, respectively. #cvnuc Read now👉 https://t.co/KFovydwBfk

In patients w/ ATTR-CM on TTR stabilizers, mortality did not differ among those w/ 99mTc-PYP visual grades 2 & 3, but higher NAC stage & worse NYHA class remained strong & independent predictors of mortality. #cvnuc Read now👉 https://t.co/eDZYJWyWfY

Multiangle data acquisition and AI enhanced mapping to multiangle data both enhance image resolution in cardiac CZT SPECT perfusion imaging. Promising for improved diagnostic accuracy! @YaleMed @YaleCardiology #cvnuc Read now👉 https://t.co/q7BqlAmKNe

ACC/AHA ESC multi-society guideline highlights-Where cardiac PET is endorsed, gaps remaining, what’s next! Expanding Class I & II recs for perfusion, viability & inflammation imaging. ESC gives more Class I recs. #CVNuc #JNC #THINKPET @almallahmo @mariaalwan @methodisthosp Read

The value of hybrid SPECT/CT MPI in management: patients w/ CAC benefited from statin, beta-blockers associated w/ improved survival in pts w/ ischemia. @robertjhmiller @WaseemHijazi1 @LibinInstitute @UCalgary Editorial by Catherine X. Wright & Erica S. Spatz. Read now👇

When utilizing DLAC maps for reconstruction of sestamibi CZT-SPECT, there is no more drop in the RCA territory uptake w/ lower fluctuations in stress-to-rest activity, aligning closely w/ the results observed using Rb-PET in the same patients @nancyclotep. Editorial by Teemu

Do patients with HFimpEF have lower cardiac sympathetic hyperactivity? In this issue, Ishibashi et al identified H/M ratio as an independent predictor of HFimpEF. Editorial by Hein Verberne #cvnuc Read now👉 https://t.co/2E6TS65VNF

Fully automated volumetric quantification of FDG PET for cardiac sarcoidosis based on CT attenuation map-derived volumetry is feasible, rapid, & has high prediction performance. @robertjhmiller @UCalgary @Piotr_JSlomka @SmidtHeart Editorial by Osamu Manabe @ Jichi Medical

Serial PET for clinical indications shows MFR doesn't change much over time but increases post-revascularization. Serial MFR & perfusion assessments improve CV risk prediction. @attilafehermd @YaleCardiology #cvnuc @edwardmillermd @INikolakopoulos @ibolya_csecs @YaleIMed.

Does correcting MFR for rate-pressure product improve risk prediction? In a study of 4464 patients referred for stress PET MPI, uncorrected MFR < 2 was associated with a higher CV risk, even when corrected MFR was >=2. @almallahmo @MethodistHosp. Editorial by @danielmhuck

ICYMI: Cardiac PET & PET/CT have earned 🆕 indications in recently published guidelines from the ACC/AHA, @escardio, & the @ISHLT. To help you translate these recommendations into practice, @JNCjournal published a State-of-the-Art Review article documenting where PET is now

On PET, how does MFR change across the BMI spectrum? Does BMI modify the association between MFR & adverse outcomes? All the answers & more can be found in this new publication by Mahmoud Al Rifai, MD, MPH, et al. Read now👉 https://t.co/GYLCmulEeB @kershawpatel @almallahmo